LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for CARsgen Therapeutics and Millions of Other Companies

Sign up for full access to CARsgen Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Expansion Opportunities CARsgen Therapeutics has recently invested $157 million in a facility in Durham, North Carolina, indicating a potential expansion or growth phase. This move presents opportunities for partnerships, sales collaborations, and market penetration in the U.S. biotechnology sector.

Collaboration Potential The partnerships with Moderna and Pharmatching GmbH demonstrate CARsgen's willingness to collaborate with key players in the industry. This signals potential joint research, product development, and commercialization opportunities that can enhance sales channels and strengthen market presence.

Innovative Product Pipeline CARsgen's focus on novel technologies and product pipeline with global rights showcases a commitment to innovation. Business development professionals can leverage these unique offerings to explore new markets, attract investor interest, and secure strategic partnerships for increased sales growth.

Market Differentiation The collaboration with Moderna on Claudin18.2 cancer therapies highlights CARsgen's position as a leader in addressing major challenges in CAR T-cell therapies. This market differentiation can be harnessed by sales teams to emphasize unique selling propositions and drive competitive advantage in client engagements.

Financial Stability With a revenue ranging from $100 million to $1 billion and funding of $186 million, CARsgen exhibits financial stability. Sales development representatives can use this financial strength as a selling point to instill confidence in potential clients, negotiate favorable deals, and expand the customer base.

Similar companies to CARsgen Therapeutics

✕

Access Insights for CARsgen Therapeutics and Millions of Other Companies

Sign up for full access to CARsgen Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

CARsgen Therapeutics Tech Stack

CARsgen Therapeutics uses 8 technology products and services including Quickbooks Online, Baidu Analytics, Lightbox, and more. Explore CARsgen Therapeutics's tech stack below.

  • Quickbooks Online
    Accounting
  • Baidu Analytics
    Analytics
  • Lightbox
    Javascript Libraries
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • X-XSS-Protection
    Security
  • Google Tag Manager
    Tag Management
  • Bootstrap
    UI Frameworks

Media & News

CARsgen Therapeutics's Email Address Formats

CARsgen Therapeutics uses at least 1 format(s):
CARsgen Therapeutics Email FormatsExamplePercentage
FirstLast@carsgen.comJohnDoe@carsgen.com
54%
First.Last@carsgen.comJohn.Doe@carsgen.com
29%
FirstLa@carsgen.comJohnDo@carsgen.com
12%
FirLast@carsgen.comJohDoe@carsgen.com
5%

Frequently Asked Questions

Where is CARsgen Therapeutics's headquarters located?

Minus sign iconPlus sign iconCARsgen Therapeutics's main headquarters is located at 1F, Building 2, No.466, Yindu Rd Shanghai, Shanghai 200231 CN. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is CARsgen Therapeutics's phone number?

Minus sign iconPlus sign icon You can contact CARsgen Therapeutics's main corporate office by phone at
✕

Access Insights for CARsgen Therapeutics and Millions of Other Companies

Sign up for full access to CARsgen Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+86-21-5448-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CARsgen Therapeutics's official website and social media links?

Minus sign iconPlus sign iconCARsgen Therapeutics's official website is carsgen.com and has social profiles on LinkedIn.

How much revenue does CARsgen Therapeutics generate?

Minus sign iconPlus sign icon As of October 2024, CARsgen Therapeutics's annual revenue reached $750M.

What is CARsgen Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconCARsgen Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CARsgen Therapeutics have currently?

Minus sign iconPlus sign iconAs of October 2024, CARsgen Therapeutics has approximately 501 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Medical Officer: R. B.Vice President - Solid Tumors: S. A.Head Of Technical Operations: B. H.. Explore CARsgen Therapeutics's employee directory with LeadIQ.

What industry does CARsgen Therapeutics belong to?

Minus sign iconPlus sign iconCARsgen Therapeutics operates in the Biotechnology Research industry.

What technology does CARsgen Therapeutics use?

Minus sign iconPlus sign iconCARsgen Therapeutics's tech stack includes Quickbooks OnlineBaidu AnalyticsLightboxPHPYoast SEOX-XSS-ProtectionGoogle Tag ManagerBootstrap.

What is CARsgen Therapeutics's email format?

Minus sign iconPlus sign iconCARsgen Therapeutics's email format typically follows the pattern of . Find more CARsgen Therapeutics email formats with LeadIQ.

How much funding has CARsgen Therapeutics raised to date?

Minus sign iconPlus sign icon As of October 2024, CARsgen Therapeutics has raised $186M in funding. The last funding round occurred on Nov 02, 2020 for $186M.

When was CARsgen Therapeutics founded?

Minus sign iconPlus sign iconCARsgen Therapeutics was founded in 2014.
CARsgen Therapeutics

CARsgen Therapeutics

Biotechnology ResearchShanghai, China501-1000 Employees

CARsgen is a biopharmaceutical company with operations in China and the U.S. focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. The company has built an integrated cell therapy platform with in-house capabilities that span target discovery, antibody development, clinical trials, and commercial-scale manufacturing. CARsgen has internally developed novel technologies and a product pipeline with global rights to address major challenges of CAR T-cell therapies, such as improving the safety profile, enhancing the efficacy in treating solid tumors, and reducing treatment costs. Our vision is to become a global biopharmaceutical leader that brings innovative and differentiated cell therapies to cancer patients worldwide and makes cancer curable.

Media contact: pr@carsgen.com

✕

Access Insights for CARsgen Therapeutics and Millions of Other Companies

Sign up for full access to CARsgen Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
1F, Building 2, No.466, Yindu Rd Shanghai, Shanghai 200231 CN
Phone number
✕

Access Insights for CARsgen Therapeutics and Millions of Other Companies

Sign up for full access to CARsgen Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+86-21-5448-****
Website
carsgen.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
501-1000

Section iconMedia & News

Section iconFunding & Financials

  • $186M

    CARsgen Therapeutics has raised a total of $186M of funding over 4 rounds. Their latest funding round was raised on Nov 02, 2020 in the amount of $186M.

  • $100M$1B

    CARsgen Therapeutics's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $186M

    CARsgen Therapeutics has raised a total of $186M of funding over 4 rounds. Their latest funding round was raised on Nov 02, 2020 in the amount of $186M.

  • $100M$1B

    CARsgen Therapeutics's revenue is in the range of $100M$1B

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for CARsgen Therapeutics and Millions of Other Companies

Sign up for full access to CARsgen Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.